Skip to main content

ADVERTISEMENT

Jolynn Tumolo

News
10/12/2021
Jolynn Tumolo
“Given the utilization of secukinumab as a therapy for psoriasis and psoriatic arthritis, appropriate screening and risk stratification could help limit morbidity and mortality that can be associated with secukinumab-induced inflammatory...
“Given the utilization of secukinumab as a therapy for psoriasis and psoriatic arthritis, appropriate screening and risk stratification could help limit morbidity and mortality that can be associated with secukinumab-induced inflammatory...
“Given the utilization of...
10/12/2021
First Report Managed Care
News
10/12/2021
Jolynn Tumolo
“The findings of this cross-sectional study suggest that despite more stringent composite score thresholds for 2020 payment adjustments, most practices achieved exceptional performance,” authors wrote.
“The findings of this cross-sectional study suggest that despite more stringent composite score thresholds for 2020 payment adjustments, most practices achieved exceptional performance,” authors wrote.
“The findings of this...
10/12/2021
First Report Managed Care
News
10/08/2021
Jolynn Tumolo
“The most significant finding,” Dr Oliver wrote, “was the lack of high-quality evidence for commonly acknowledged interactions. High-quality interaction studies involving different phenotypes in drug metabolism (cytochrome P450) and...
“The most significant finding,” Dr Oliver wrote, “was the lack of high-quality evidence for commonly acknowledged interactions. High-quality interaction studies involving different phenotypes in drug metabolism (cytochrome P450) and...
“The most significant finding,”...
10/08/2021
Pharmacy Learning Network
News
10/07/2021
Jolynn Tumolo
Fresenius Kabi USA is recalling four lots of morphine sulfate injection because of cracked vials and a subsequent lack of sterility assurance.
Fresenius Kabi USA is recalling four lots of morphine sulfate injection because of cracked vials and a subsequent lack of sterility assurance.
Fresenius Kabi USA is recalling...
10/07/2021
Pharmacy Learning Network
News
10/07/2021
Jolynn Tumolo
The FDA issued a Class II recall for a prescription medication used to treat seizures and bipolar disorder
The FDA issued a Class II recall for a prescription medication used to treat seizures and bipolar disorder
The FDA issued a Class II recall...
10/07/2021
Pharmacy Learning Network
News
10/07/2021
Jolynn Tumolo
An over-the-counter pain reliever, fever reducer, cough suppressant/expectorant, and nasal decongestant is being recalled.
An over-the-counter pain reliever, fever reducer, cough suppressant/expectorant, and nasal decongestant is being recalled.
An over-the-counter pain...
10/07/2021
Pharmacy Learning Network
News
10/07/2021
Jolynn Tumolo
“In this cohort study, we have demonstrated that one-stop treatment of comorbidities is likely worthwhile and an efficient strategy enhancing financial equity in service provision for people with multiple conditions in sub-Saharan Africa...
“In this cohort study, we have demonstrated that one-stop treatment of comorbidities is likely worthwhile and an efficient strategy enhancing financial equity in service provision for people with multiple conditions in sub-Saharan Africa...
“In this cohort study, we have...
10/07/2021
First Report Managed Care
News
10/07/2021
Jolynn Tumolo
“In 2001, one-half of all expenditures on prescription drugs were concentrated in 6.0% of the US population,” researchers wrote, “but by 2018, this proportion had decreased to 2.3%.”
“In 2001, one-half of all expenditures on prescription drugs were concentrated in 6.0% of the US population,” researchers wrote, “but by 2018, this proportion had decreased to 2.3%.”
“In 2001, one-half of all...
10/07/2021
First Report Managed Care
News
10/06/2021
Jolynn Tumolo
“Additional studies are needed to better understand unique out-of-pocket financial considerations among Black individuals and develop targeted approaches to reduce both the financial and overall burden of atopic dermatitis,” concluded...
“Additional studies are needed to better understand unique out-of-pocket financial considerations among Black individuals and develop targeted approaches to reduce both the financial and overall burden of atopic dermatitis,” concluded...
“Additional studies are needed...
10/06/2021
First Report Managed Care
News
10/06/2021
Jolynn Tumolo
A new study finds parents and grandparents of people with attention-deficit/hyperactivity disorder (ADHD) are at increased risk of Alzheimer’s disease and dementia.
A new study finds parents and grandparents of people with attention-deficit/hyperactivity disorder (ADHD) are at increased risk of Alzheimer’s disease and dementia.
A new study finds parents and...
10/06/2021
Psych Congress Network